KASL clinical practice guidelines for management of chronic hepatitis B

Information about the committee and funds The Committee for the Revision of Clinical Practice Guidelines for CHB 2018, launched in accordance with the initiative of the Board of Directors of the KASL and approved by the council, was composed of ten hepatologists. Levels of evidence and grades of rec...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Clinical and molecular hepatology Ročník 25; číslo 2; s. 93 - 159
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Korea (South) Korean Association for the Study of the Liver 01.06.2019 The Korean Association for the Study of the Liver 대한간학회
Témata:	Antibodies Antigens Antiviral Agents - therapeutic use Associations Boards of directors Chronic hepatitis B Clinical medicine Clinical practice guidelines Committees DNA, Viral - blood Drug resistance Epidemiology Hepatitis B Hepatitis B Antibodies - blood Hepatitis B e Antigens - blood Hepatitis B Surface Antigens - blood Hepatitis B virus - genetics Hepatitis B, Chronic - diagnosis Hepatitis B, Chronic - drug therapy Hepatitis B, Chronic - immunology Humans KASL guidelines Liver cancer Liver Cirrhosis - complications Liver Cirrhosis - diagnosis Natural history Patients Review Serology Sustained Virologic Response Treatment Viruses 내과학 Chronic hepatitis B KASL guidelines Treatment
ISSN:	2287-2728, 2287-285X, 2287-285X
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!